Structure of Tofacitinib CAS 477600-75-2

Tofacitinib CAS 477600-75-2

Identification

CAS Number

477600-75-2

Name

Tofacitinib

Synonyms

1-piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- [ACD/Index Name]
3-{(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile
3-{(3R,4R)-4-methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
3-{(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanonitril
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrilato [ACD/IUPAC Name]
3-{(3R,4R)-4-Méthyl-3-[méthyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-pipéridinyl}-3-oxopropanenitrile [French] [ACD/IUPAC Name]
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropannitril [German] [ACD/IUPAC Name]
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
477600-75-2 [RN]
Tasocitinib
Tofacitinib [INN] [USAN] [Wiki]
Tofacitinib [Spanish] [INN]
Tofacitinib [French] [INN]
Tofacitinibum [Latin] [INN]
(3r,4r)-Tofacitinib
[477600-75-2]
1259404-17-5, 477600-75-2, 540737-29-9
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-b-oxo-, (3R,4R)-
1-piperidinepropanenitrile, 4-methyl-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3r,4r)-
3-((3R,4r)-4-methyl-3-(methyl (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE
3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile(wxc01414)
3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidinyl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidyl]-3-oxo-propanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)piperidin-1-yl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)piperidin-1-yl]-3-oxo-propanenitrile
3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
3-keto-3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidyl]propionitrile
87LA6FU830
937669-80-2 [RN]
ck2inhibitor10
CP-690,550|CP-690550|tasocitinib|Xeljanz®
cp6905503-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
GS-6106
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71200
MFCD11035919 [MDL number]
MFCD22628813 [MDL number]
MI1
tasocitinib (cp 690550)
Tasocitinib; Tofacitinibum
Tasocitinib;CP-690550;CP 690550;CP690550
tasocitinib???tofacitinib???cp 690550
Tofacitinib (CP-690550, Tasocitinib)
Tofacitinib (CP-690550,Tasocitinib)
tofacitinib(cp-690550)
tofacitinib(cp-690550,tasocitinib)
tofacitinib,cp-690550
tofacitinibum
UNII:87LA6FU830
UNII-87LA6FU830
Xeljanz®
тофацитиниб
توفاسيتينيب
托法替布

SMILES

C[[email protected]@H]1CCN(C[[email protected]@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N

StdInChI

InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1

StdInChIKey

UJLAWZDWDVHWOW-YPMHNXCESA-N

Molecular Formula

C16H20N6O

Molecular Weight

312.370

MDL Number

MFCD11035919

Properties

Appearance

White powder

Safety Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Tofacitinib CAS 477600-75-2

Identification Methods

HNMR, HPLC

Available document

GMP, DMF

Purity

98% min

Shelf Life

2 years

Storage

Under room temperature away from light

Known Application

Often used as nucleotide antiviral drugs.

Caming Pharmaceutical Ltd

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details. http://www.caming.com/tofacitinib-cas-477600-75-2/

Watson International Ltd

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details. http://www.watson-int.com/tofacitinib-cas-477600-75-2/